: FDA advisers vote in favor of Pfizer’s maternal RSV vaccine Posted on May 18, 2023 By Charlielikes If approved, vaccine would be the first in U.S. to protect babies against leading cause of hospitalization Stock Market Tags:advisers, billy wilkins, favor, fda, in, market, maternal, of, pfizer’s, rsv, stock, stock market, vaccine, vote